-The Hindu Achieving universal health coverage through an equitable system is among the key goals of India's 12th Plan. Within the overall objective of creating an entitlement-based health care system, one of the challenges is access to medicines. The High Level Expert Group instituted by the Planning Commission on Universal Health Coverage underscores serious policy distortions and inefficiencies that stand in the way of making essential medicines accessible to all. A...
More »SEARCH RESULT
Education experts pitch for major changes in RTE Act by Rashmi R Parida
The goals of the Right to Education (RTE) Act are unrealistic and unachievable in its entirety education experts and policymakers said at a conference here today, and endorsed the need for more dialogues with civil society, government agencies and educational service providers to bring the landmark legislation to fruition. There is an imperative need to look afresh into the RTE Act, iron out its ambiguities and...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »An end to endosulfan?
India has decided to join a global consensus to end the production and use of endosulfan after being allowed 11 years to phase it out and promised financial assistance. This decision is not irreversible since India has to ratify its own decision. An absolutely final position can be adopted after the results of more elaborate studies on extensive use are available since a causal link between the health hazards in...
More »Govt explores capping FDI in pharma by CH Unnikrishnan
The Indian government is exploring a proposal to reduce the limit on foreign direct investment (FDI) allowed in the pharmaceutical industry through the automatic route to 49% from 100% amid concerns over the takeover of local drug makers by overseas firms. Officials from the ministry of commerce and industry and the ministry of health have had multiple rounds of discussions on the proposal following a note written to them by the finance...
More »